RANDOMIZED PHASE III TRIAL OF CARBOPLATIN (AUC 7.5) AND PACLITAXEL

卵巢癌是世界上第四大最常见的女性癌症。 美国的 每年有24，000名妇女被新诊断出患有这种疾病，其中 13，600人最终将死于疾病。 现在最常见的是 致命的妇科恶性肿瘤，在过去的三十年里， 卵巢癌发病率稳步缓慢上升。 不幸的是，只有大约30%的卵巢癌是局部的， 并且在他们最初的时候适合于完全手术切除 演示文稿.

Ovarian carcinoma is the fourth most frequent cancer in women in the United States. It is newly diagnosed in 24,000 women each year, of whom 13,600 will eventually die of their disease. It is now the most common fatal gynecological malignancy, and over the past three decades, there has been a steady slow rise in ovarian cancer incidence. Unfortuanetely, only about 30 percent of ovarian carcinoma are localized and amenable to complete surgical resection at the time of their initial presentation.